Methods for treatment of multiple sclerosis with statins

Details for Australian Patent Application No. 2003202797 (hide)

Owner Novimmune S.A.

Inventors Mach, Francois

Agent Fisher Adams Kelly

Pub. Number AU-B-2003202797

PCT Number PCT/IB03/00646

PCT Pub. Number WO2003/061703

Priority 10/056,608 23.01.02 US

Filing date 22 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 29 November 2007

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 10/056,608 23.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003202797

29 November 2007 Application Accepted

  Published as AU-B-2003202797

3 April 2008 Standard Patent Sealed

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003202798-METHOD AND SYSTEM FOR FEEBASED COMMERCIAL-FREE TELEVISION VIEWING

2003202796-Sintering ultrahigh molecular weight polyethylene